Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natalizumab De-escalation to Interferon-beta-1b in RR-MS
NCT01701856Phase 4Terminated
- Sponsor
- Gobbi Novag
- Start
- Sep 2012
- Primary completion
- Oct 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon beta-1b in multiple sclerosis (MS), sponsored by Gobbi Novag. Started Sep 2012; status: terminated.
02
Drugs
interferon beta-1b
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01701856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701856.